Analyst Ratings for Neoleukin Therapeutics (NLTX)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 2.5 / 10
Percentile Rank: 20%
Rating Score: 2.5 / 10
Percentile Rank: 20%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/3/2023 | Guggenheim | Charles Zhu | Downgrade | Neutral (Buy) |
N/A (N/A) |
0.51 (3.49) |
584.31% | Details |
| 11/16/2022 | H.C. Wainwright | Robert Burns | Downgrade | Neutral (Buy) |
N/A (N/A) |
0.42 (3.49) |
730.95% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
